Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;51(1):169-179.
doi: 10.1016/j.ultrasmedbio.2024.09.021. Epub 2024 Oct 19.

Amplitude-Modulation Frequency Optimization for Enhancing Harmonic Motion Imaging Performance of Breast Tumors in the Clinic

Yangpei Liu  1 , Md Murad Hossain  1 , Xiaoyue Judy Li  1 , Elisa E Konofagou  2
Affiliations

Amplitude-Modulation Frequency Optimization for Enhancing Harmonic Motion Imaging Performance of Breast Tumors in the Clinic

Yangpei Liu et al. Ultrasound Med Biol. 2025 Jan.

Abstract

Objective: Elastography images tissue mechanical responses and infers the underlying properties to aid diagnosis and treatment response monitoring. The estimation of absolute or relative tumor properties may vary with dimensions even when the mechanical properties remain constant. Harmonic motion imaging (HMI) uses amplitude-modulated (AM) focused ultrasound to interrogate the targeted tissue's viscoelastic properties. In this study, effects of AM frequencies on HMI were investigated in terms of inclusion relative stiffness and size estimation.

Methods: AM frequencies from 200 to 600 Hz in steps of 100 Hz were considered using a 5.3-kPa phantom with cylindrical inclusions (Young's modulus: 22, 31, 44, 56 kPa, and diameter: 4.8, 8.1, 13.6, 19.8 mm) to optimize the performance of HMI in characterizing tumors with the same mechanical properties and of different dimensions.

Results: Consistent displacement ratios (DRs) (17.5% variation) of the inclusion to background were obtained with 200-Hz AM for breast-tumor-mimicking inclusions albeit a suboptimal inclusion size estimation obtained. 400-Hz was otherwise used for small and low-contrast inclusions (4.8 mm, 22 or 31 kPa). A linear relationship (R2 = 0.9043) was found between the inverse DR at these frequencies and the Young's modulus ratio. 400 Hz obtained the most accurate inclusion size estimation with an overall estimation error on the lateral dimension of 0.5 mm. In vivo imaging of breast cancer patients (n = 5) was performed at 200 or 400 Hz.

Conclusion: The results presented herein indicate that the HMI AM frequency could be optimized adaptively in cases of different applications, i.e., at 200 or 400 Hz, depending on whether aimed for consistent DR measurement for tumor response assessment or tumor margin delineation for surgical planning. HMI may thus be capable of predicting the pathologic endpoint of tumors in response to neoadjuvant chemotherapy (NACT) as early as 3 weeks into treatment.

Keywords: Amplitude modulation frequency; Breast tumor; Elastography; Focused ultrasound; Harmonic motion imaging; Neoadjuvant chemotherapy.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare no conflicts of interest.

Similar articles

See all similar articles

References

    1. Siegel Mph RL, Miller KD, Sandeep N, Mbbs W, Ahmedin ∣, Dvm J, et al. Cancer statistics, 2023. CA Cancer J Clin 2023;73:17–48. 10.3322/caac.21763. - DOI - PubMed
    1. Keune JD, Jeffe DB, Schootman M, Hoffman A, Gillanders WE, Aft RL. Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer. Am J Surg 2010;199:477–84. 10.1016/j.amjsurg.2009.03.012. - DOI - PMC - PubMed
    1. Chagpar AB, Middleton LP, Sahin AA, Dempsey P, Buzdar AU, Mirza AN, et al. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg 2006;243:257–64. 10.1097/01.sla.0000197714.14318.6f. - DOI - PMC - PubMed
    1. Gu J, Polley EC, Denis M, Carter JM, Pruthi S, Gregory AV, et al. Early assessment of shear wave elastography parameters foresees the response to neoadjuvant chemotherapy in patients with invasive breast cancer. Breast Cancer Res 2021;23:52. 10.1186/s13058-021-01429-4. - DOI - PMC - PubMed
    1. Tai H, Margolis R, Li J, Hoyt K. H-Scan Ultrasound Monitoring of Breast Cancer Response to Chemotherapy and Validation with Diffusion-Weighted Magnetic Resonance Imaging. Journal of Ultrasound in Medicine 2022. 10.1002/JUM.16143. - DOI - PMC - PubMed

Publication types

LinkOut - more resources